Keywords: Liver, Liver
Motivation: Enhance precision in hepatocellular carcinoma (HCC) diagnosis by determining the superior contrast agent.
Goal(s): Compare Gd-EOB-DTPA and Gd-BOPTA efficiency in displaying LI-RADS-recommended HCC features.
Approach: Retrospective analysis of 98 HCC lesions using Gd-EOB-DTPA-MR and Gd-BOPTA-MR, assessing enhancement patterns and lesion-to-liver contrast.
Results: Significantly varied capsule enhancement and lesion-to-liver contrast were observed in specific phases. Both agents demonstrated effective display capabilities (AUC>0.750) and excellent overall performance (AUC>0.950) across all phases.
Impact: These findings offer crucial insights for clinicians and researchers, facilitating informed selection of contrast agents for accurate HCC diagnosis. Future investigations may focus on refining imaging protocols, ultimately improving patient care and management decisions.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords